Literature DB >> 32651677

Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin.

Soner Celik1, Sinan Ozkavukcu2,3, Ciler Celik-Ozenci4.   

Abstract

PURPOSE: We investigated whether expression of activator proteins that control follicle reserve and growth change after ovarian tissue vitrification and re-transplantation. Moreover, we assessed whether inhibition of mTOR signaling pathway by rapamycin would protect primordial follicle reserve after ovarian tissue freezing/thawing and re-transplantation.
METHODS: Fresh control, frozen/thawed, fresh-transplanted, frozen/thawed and transplanted, rapamycin/control, rapamycin fresh-transplanted, and rapamycin frozen-thawed and transplanted groups were established in rats. After freezing and thawing process, two ovaries were transplanted into the back muscle of the same rat. After 2 weeks, grafts were harvested, fixed, and embedded into paraffin block. Normal and atretic primordial/growing follicle count was performed in all groups. Ovarian tissues were evaluated for the dynamic expressions of Gdf-9, Bmp-15, KitL, Lif, Fgf-2, and p-s6K using immunohistochemistry, and H-score analyses were done.
RESULTS: Primordial follicle reserve reduced almost 50% after ovarian tissue re-transplantation. Expression of Gdf-9 and Lif increased significantly in primordial and growing follicles in frozen-thawed, fresh-transplanted, and frozen/thawed and transplanted groups, whereas expression of Bmp-15, KitL, and Fgf-2 decreased in primordial follicles. Freezing and thawing of ovarian tissue solely significantly increased p-s6K expression in primordial follicles, and on the other hand, suppression of mTORC1 pathway using rapamycin preserved the primordial follicle pool.
CONCLUSION: Altered expressions of activator proteins that regulate primordial follicle reserve and growth may lead to primordial follicle loss and rapamycin treatment can protect ovarian reserve after ovarian tissue cryopreservation/transplantation.

Entities:  

Keywords:  Fertility preservation; Ovarian tissue cryopreservation; Primordial follicle reserve; Rapamycin; Transplantation; mTOR

Mesh:

Substances:

Year:  2020        PMID: 32651677      PMCID: PMC7492284          DOI: 10.1007/s10815-020-01875-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  59 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Analysis of the Effect of Leukemia Inhibitory Factor on Follicular Growth in Cultured Murine Ovarian Tissue.

Authors:  Kouji Komatsu; Tomoko Koya; Jingwen Wang; Mamoru Yamashita; Fumitaka Kikkawa; Akira Iwase
Journal:  Biol Reprod       Date:  2015-06-03       Impact factor: 4.285

3.  Possible improvements in human ovarian grafting by various host and graft treatments.

Authors:  Or Friedman; Raoul Orvieto; Benjamin Fisch; Carmela Felz; Enrique Freud; Avi Ben-Haroush; Ronit Abir
Journal:  Hum Reprod       Date:  2011-11-23       Impact factor: 6.918

4.  Inhibition of mTOR Signaling Pathway Delays Follicle Formation in Mice.

Authors:  Jing Zhang; Wenwen Liu; Xinhui Sun; Feifei Kong; Ye Zhu; Yue Lei; Youqiang Su; Yiping Su; Jing Li
Journal:  J Cell Physiol       Date:  2016-06-24       Impact factor: 6.384

5.  Efficiency of equilibrium cooling and vitrification procedures for the cryopreservation of ovarian tissue: comparative analysis between human and animal models.

Authors:  Fulvio Gandolfi; Alessio Paffoni; Elide Papasso Brambilla; Silvia Bonetti; Tiziana A L Brevini; Guido Ragni
Journal:  Fertil Steril       Date:  2006-04       Impact factor: 7.329

6.  Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenografting.

Authors:  Anne-Sophie Van Eyck; Bénédicte Francine Jordan; Bernard Gallez; Jean-François Heilier; Anne Van Langendonckt; Jacques Donnez
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

Review 7.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321

8.  Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants.

Authors:  Reza Soleimani; Elke Heytens; Kutluk Oktay
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.

Authors:  Linyan Zhou; Yanqiu Xie; Song Li; Yihua Liang; Qi Qiu; Haiyan Lin; Qingxue Zhang
Journal:  J Ovarian Res       Date:  2017-08-16       Impact factor: 4.234

10.  Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity.

Authors:  Yuji Tanaka; Fuminori Kimura; Luyi Zheng; Shoji Kaku; Akie Takebayashi; Kyoko Kasahara; Shunichiro Tsuji; Takashi Murakami
Journal:  Exp Anim       Date:  2018-06-22
View more
  2 in total

1.  Expression of pro-apoptotic and anti-apoptotic proteins in granulosa cells of women with diminished ovarian reserve.

Authors:  Sibel Bulgurcuoglu Kuran; Ayse Altun; Burcin Karamustafaoglu Balci; Ilknur Keskin; Meryem Hocaoglu
Journal:  J Assist Reprod Genet       Date:  2022-02-10       Impact factor: 3.412

2.  Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage.

Authors:  Xiuying Chen; Zhijing Tang; Haiyun Guan; Hexia Xia; Chao Gu; Yan Xu; Bin Li; Wei Zhang
Journal:  J Reprod Dev       Date:  2022-06-19       Impact factor: 2.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.